Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × apatinib × NET × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 14 Gynecologic 5 Thoracic 3 Sarcoma 1 Other solid neoplasm 1 NET 1 Endocrine 1 Breast 1

Conditions

Neuroendocrine Tumors 1

Interventions

lutetium Lu 177 dotatate 1 apatinib 1 Surveys and Questionnaires 1 Radiomics 1 Engineering 1 Endoscopic Mucosal Resection 1 Biological Products 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06764368 2025-01-08

Phase II Study of Adebrelimab, Chemotherapy, and Apatinib for Advanced Pulmonary Neuroendocrine Tumors

Beijing Chest Hospital

Phase 2 Not yet recruiting

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡